Coupled plasma filtration adsorption in experimental septic shock
Authors:
Sýkora Roman 1,2; Chvojka Jiří 1,2; Kroužecký Aleš 1,2; Raděj Jaroslav 1,2; Kuncová Jitka 3; Varnerová Veronika 2; Karvunidis Thomas 1,2; Novák Ivan 1,2; Matějovič Martin 1,2
Authors‘ workplace:
Jednotka intenzivní péče, I. interní klinka, Fakultní nemocnice Plzeň
1; Lékařská fakulta v Plzni, Univerzita Karlova v Praze
2; Ústav fyziologie, Lékařská fakulta v Plzni, Univerzita Karlova v Praze
3
Published in:
Anest. intenziv. Med., 21, 2010, č. 2, s. 95-103
Category:
Intensive Care Medicine - Original Paper
Overview
Objective:
Coupled plasma filtration adsorption (CPFA) was developed as an adsorptive hemopurification method aimed at nonselective removal of circulating soluble mediators potentially involved in the pathogenesis of sepsis. We hypothesized that this nonselective hemopurification could protect from detrimental consequences of long- -term, volume-resuscitated porcine septic shock.
Design and setting:
Randomized, controlled experimental study.
Materials and methods:
In sixteen anesthetized and mechanically ventilated piglets hyperdynamic septic shock secondary to peritonitis was induced by intraperitoneal inoculation with faeces. The piglets were treated with fluid resuscitation and norepinephrine infusion as needed to maintain mean arterial pressure above 65 mm Hg for 22 hours. After 12 hours of peritonitis the animals were randomized to receive either supportive treatment (Control, n = 8) or CPFA treatment (CPFA, n = 8).
Results:
Systemic, hepatosplanchnic and renal hemodynamics, oxygen exchange, energy metabolism (lactate/pyruvate and ketone body ratios), ileal mucosal and renal cortex microcirculation, systemic inflammation (TNF-α, IL-6), nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+nitrites), endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and at 12, 18, and 22 hours of peritonitis. CPFA did not delay the development of hypotension nor reduced the dose of norepinephrine. The treatment failed to attenuate sepsis-induced alterations in microcirculation, surrogate markers of cellular energetics, endothelial injury and systemic inflammation. Similarly, CPFA did not protect from lung and liver dysfunction or aggravated sepsis-induced disturbances in coagulation and oxidative/nitrosative stress.
Conclusions:
In this porcine model of septic shock, early treatment with CPFA was incapable of reversing sepsis-induced disturbances in various biological pathways and organ systems. Both the efficacy and safety of this method require further rigorous experimental validation in clinically relevant models.
Keywords:
sepsis – septic shock – experimental model – coupled plasma filtration adsorption – microcirculation – energy metabolism – oxidative stress – nitrosative stress – coagulation – endothelial dysfunction
Sources
1. Bellomo, R. et al. Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis. Int. J. Artif Organs, 2005, 28, p. 450–458.
2. Vincent, J. L. et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock, 2005, 23, p. 400–405.
3. Schefold, J. C. et al. A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a. Shock, 2007, 28, p. 418–425.
4. Formica, M. et al. Coupled plasma filtration adsorption. Contrib. Nephrol., 2007, 156, p. 405–410.
5. Bellomo, R. et al., Tetta, C., Ronco, C. Coupled plasma filtration adsorption. Intensive Care Med., 2003, 29, p. 1222–1228.
6. Ronco, C. et al. Coupled plasma filtration adsorption: rationale, technical development and early clinical experience. Blood Purif., 2003, 21, p. 409–416.
7. Tetta, C. et al. Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill. Kidney Int. Suppl., 1999, 72, p. S15–S19.
8. Winchester, J. F. et al. Sorbents in acute renal failure and the systemic inflammatory response syndrome. Blood Purif., 2003, 21, p. 79–84.
9. Cole, L. et al. The effect of coupled haemofiltration and adsorption on inflammatory cytokines in and ex vivo model. Nephrol. Dial. Transplant., 2002, 17, p. 1950–1956.
10. Tetta, C. et al. Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol. Dial. Transplant., 1998, 13, p. 1458–1464.
11. Ronco, C. et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit. Care Med., 2002, 30, p. 1250–1255.
12. Tetta, C. et al. Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit. Care Med., 2000, 28, p. 1526–1533.
13. Formica, M. et al. Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Intensive Care Med., 2003, 29, p. 703–708.
14. Matejovic, M. et al. Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock, 2004, 21, 458–465.
15. Matejovic, M. et al. Effects of tempol, a free radical scavenger, on long-term hyperdynamic porcine bacteremia. Crit Care Med., 2005, 33, p. 1057-1063.
16. Matejovic, M. et al. Effects of combining inducible nitric oxide synthase inhibitor and radical scavenger during porcine bacteremia. Shock, 2007, 27, p. 61–68.
17. De Backer, D. et al. How to evaluate the microcirculation: report of a round table conference. Crit. Care, 2007, 11, p. R101.
18. Szabó, A. et al. Flow motion in the intestinal villi during hemorrhagic shock: a new method to characterize the microcirculatory changes. Shock, 2004, 21, p. 320–328.
19. Bouman, C. S. et al. Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing. J. Crit. Care, 2007, 22, p. 1–12.
20. Hakim, R. M. Clinical implications of biocompatibility in blood purification membranes. Nephrol. Dial. Transplant., 2000, 15 (Suppl 2), p. 16–20.
21. Pertosa, G. et al. Clinical relevance of cytokine production in hemodialysis. Kidney Int. Suppl., 2000, 76, p. S104–S111.
22. Wratten, M. L. et al. Oxidant stress in hemodialysis: prevention and treatment strategies. Kidney Int Suppl., 2000, 76, p. S126–S132.
23. Gorbet, M. B. et al. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials, 2004, 25, p. 5681–5703.
24. Meijers, B. K. et al. Major coagulation disturbances during fractionated plasma separation and adsorption. Am. J. Transplant., 2007, 7, p. 2195–2199.
25. Reinhart, K. et al. Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis. Crit. Care Med., 2004, 32, p. 1662–1668.
26. Teatini, U. et al. Microcirculation as a novel marker of membrane biocompatibility. Int. J. Artif. Organs, 2006, 29, p. 1117–1120.
27. Sato, M. et al. Effect of different dialyzer membranes on cutaneous microcirculation during hemodialysis. Clin. Nephrol., 2006, 66, p. 426–432.
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
2010 Issue 2
Most read in this issue
- The effect of transversus abdominis plane block on post-operative pain relief: a prospective audit
- Multimodal monitoring in neurointensive care of severe traumatic brain injury
- Tomas Kadlic Memorial – Ass. Prof. Tomas Kadlic, M. D.
- Influence of age on the pharmacodynamic parameters of cisatracurium, rocuronium and vecuronium in males during total intravenous anaesthesia – a prospective study